Impact Factor
3.30
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.99
1,253 total citations
h5-index
31
h5 depth signal
Cited share
65.0%
425 of 654
Total citations
1,253
Citation footprint
Metric signal
2.00
External metric anchor
Self-citation
5.6%
70 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
2,018
Canada
223
United Kingdom
151
China
137
Italy
115
Citing Fields of Research
Transplantation
2,729
Kidney Diseases
496
Liver Diseases
279
Hematology
227
Cardiology
222
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
7,295
Articles tracked across the journal lifetime
Indexed publication set
654
425 cited publications
Last 12 months
365
30.4 publications/month
Open access share
37.8%
138 OA publications in the last year
Leading citing country
United States
2,018 citing publications
Leading citing field
Transplantation
2,729 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v4n1, 1990-
v4n1, 1990-
Active Coverage
Research Focus & Classification
Indexed Subjects
Transplantation
Broad Categories
Transplantation
MeSH Descriptors
Transplantation
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/ctr.70719
Open DOI
Belatacept Conversion in Simultaneous Pancreas‐Kidney and Liver‐Kidney Transplant Recipients: A Single‐Center Feasibility Cohort and Narrative Review
Background: Calcineurin inhibitor (CNI) nephrotoxicity drives long‐term kidney‐function decline after simultaneous pancreas‐kidney (SPK) and liver‐kidney (LK) transplantation, but belatacept conversion, as an alternative strategy, is poo...
02
DOI 10.1111/ctr.70721
Open DOI
Ultrasound‐Derived Differential Renal Volume Indexed to Recipient Body Mass Index Predicts One‐Year Kidney Graft Function: A Novel Surrogate of Graft–Recipient Size Matching
Background: Appropriate matching between donor nephron mass and recipient metabolic demand is increasingly recognized as an important determinant of kidney graft outcomes. However, practical and widely applicable methods for estimating g...
03
DOI 10.1111/ctr.70724
Open DOI
Organ Donation in the Unrepresented Patient—Ethical Challenges and Opportunities for Improvement
In the United States, if an individual not on the donor registry dies by neurologic criteria (DNC), has no documented advance directives, and has no identified next of kin—so called unbefriended patients—current law permits hospital admi...
04
DOI 10.1111/ctr.70706
Open DOI
Long‐Term Proton Pump Inhibitors in Lung Transplant Recipients: Near‐Universal Use Without Clear Impact on Clinical Outcomes Over a 20‐Year Observational Study
Background: Gastroesophageal reflux disease (GERD) is a known risk factor for chronic lung allograft dysfunction (CLAD), the main barrier to long‐term survival in lung transplant recipients (LTR). While proton pump inhibitors (PPI) are e...
05
DOI 10.1111/ctr.70715
Open DOI
Global Survey of Latent Tuberculosis Screening and Treatment Practices in Liver Transplantation
We surveyed transplant and infectious disease (ID) practitioners to better understand approaches to managing latent tuberculosis infection (LTBI) in liver transplantation (LT), an area in which high‐quality evidence is lacking. The surve...
06
DOI 10.1111/ctr.70714
Open DOI
Risk of Donor‐Derived Infections From Organ Donors Colonized or Infected With Multidrug‐Resistant Gram‐Negative Bacteria: A Systematic Review and Meta‐Analysis
Background: The presence of multidrug‐resistant Gram‐negative (MDR‐GN) organisms in solid organ transplantation (SOT) donors raises concerns regarding transplant safety. Methods: We searched PubMed and Scopus (2010–2025) for observationa...
07
DOI 10.1111/ctr.70711
Open DOI
Prioritization and Severe Primary Graft Dysfunction after Lung Transplantation
Background: Primary graft dysfunction (PGD) is the leading cause of early morbidity and mortality after lung transplantation (LTx). Critically ill candidates may receive priority on the transplant waiting list; however, the relationship ...
08
DOI 10.1111/ctr.70688
Open DOI
Race‐Neutral Glomerular Filtration Rate Projected to Increase Kidney Transplantation for Black Patients: Initial Policy Effects at a Single Center
The 2023 organ procurement and transplantation network (OPTN) policy “Modify waiting time for candidates affected by race‐inclusive eGFR calculations” for kidney transplantation (KT) was analyzed at our kidney transplant center over a 15...
09
DOI 10.1111/ctr.70696
Open DOI
Triglyceride‐ and Body Weight‐Based Nomogram for Early Postoperative Mycophenolate Mofetil Dose Selection Following Kidney Transplantation
Background: Early mycophenolic acid (MPA) exposure varies widely after kidney transplantation, and fixed initial mycophenolate mofetil (MMF) dosing may cause overexposure before therapeutic drug monitoring (TDM) becomes available. We exp...
10
DOI 10.1111/ctr.70716
Open DOI
Raman Urine Fingerprinting to Predict DGF, Assess Renal Allograft Quality, and Monitor Its State of Health
Objectives: To determine whether Raman spectroscopy‐based urine molecular fingerprinting (UMF) may predict delayed graft function (DGF) and assess renal allograft quality prior to transplant and monitor its state of health after transpla...
Bibliographical & Catalog Notes
Description based on: Vol. 1, no. 2 (Apr. 1987); title from cover.
Print issues ceased with 2013.
Also issued online.
Vol. 4, no. 1 (JAN 1990)19931221 Notice not published Printed on acid-free paper